PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
34 hedge funds and large institutions have $248M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$59.7M | |
| 2 | +$15M | |
| 3 | +$11.2M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$7.69M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.93M |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$2.08M | |
| 3 | -$1.98M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$846K |
| 5 |
D.E. Shaw & Co
New York
|
-$26.2K |